Affiliation: VTT Biotechnology
- Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancerMari Bjorkman
Medical Biotechnology, VTT Technical Research Centre of Finland, Institute for Molecular Medicine Finland and University of Turku, Turku, Finland
Int J Cancer 123:2774-81. 2008....
- Epigenetics of prostate cancer and the prospect of identification of novel drug targets by RNAi screening of epigenetic enzymesMari Bjorkman
Medical Biotechnology, VTT Technical Research Centre of Finland and University of Turku, Turku, Finland
Epigenomics 2:683-9. 2010....
- Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissuesSami Kilpinen
Medical Biotechnology, VTT Technical Research Centre and University of Turku, Itäinen Pitkäkatu 4C, Turku, Finland
Genome Biol 9:R139. 2008..This database of gene expression patterns in normal human tissues and pathological conditions covers 113 million datapoints and is available from the GeneSapiens website...